Glycopyrronium Tosylate Suppliers & Bulk Manufacturers
Available Forms:
Available Strengths: 2.4%
Reference Brands: Qbrexza (USA)
Category:
Derma Drugs
glycopyrronium tosylate is available in
and strengths such as 2.4%.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, glycopyrronium tosylate is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
glycopyrronium tosylate can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Glycopyrronium tosylate, marketed under the brand name Qbrexza in the United States, is a topical anticholinergic medication indicated for the treatment of primary axillary hyperhidrosis. Primary axillary hyperhidrosis is a chronic condition characterized by excessive underarm sweating that is not related to heat or physical activity and can significantly affect daily life and social interactions.
Glycopyrronium tosylate works by blocking muscarinic acetylcholine receptors in the sweat glands, thereby reducing the stimulation responsible for excessive sweat production. It is formulated as a pre-moistened, single-use topical cloth that allows localized application directly to the affected area. This targeted delivery helps minimize systemic absorption while providing effective control of sweating.
The medication is approved for use in both adult and pediatric patients within the indicated age range, offering a non-invasive alternative to oral anticholinergic therapies or injectable treatments. Glycopyrronium tosylate is generally applied once daily and is designed for convenient, at-home use. Its topical formulation makes it a preferred option for patients seeking effective management of axillary hyperhidrosis with a reduced risk of widespread anticholinergic side effects.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing